|
Pankreaskrebs 48 Arzneien ars. ars-i. aur-m.* bar-c. bar-i. bar-m. bell. cadm-i. cadm-p. cadm-s. calc-ar. carb-an.* carb-v. calc-i. calc-ox. carc. card-m. cean. chel. coloc. con.** euph. hydr. iod. ion-rad. iris. kali-ar. kali-i. kali-sil. lyc. methyl. myric. nat-s. orni. phos.* psor. rad-br. rhus-v. scir. sep. sil. spong. sul-i. sulph. thuj. vario. x-ray. zinc. keine Fälle=ein- >1-2 Fälle=zwei- >2 Fälle=Drei- >5 Fälle=Vier- >10 Fälle=FÜNF-wertig ()=BegleitTherapie *=palliativ **=TeilWirkung ***=1-Jahr ****5-Jahre-Nachbeobachtung Complete-Nachträge wichtig, bzw. verlässlich |
| ^ | ars | rmk, wrj2 |
| ^ | ars-i | Goswami, CR |
| ^ | aur-m | rzh* |
| ^ | bar-c | sne |
| ^ | bar-i | rmk |
| ^ | bar-m | Stauffer, CR |
| ^ | bell | sne |
| ^ | cadm-i | gm1 |
| ^ | cadm-p | Goswami, CR |
| ^ | cadm-s | rmk1, wrj2 |
| ^ | calc-ar | gm, ptk1 |
| ^ | carb-an | sne2/Hasbrouck* hr, snd, wrj2 |
| ^ | carb-v | Farrington, CR |
| ^ | calc-i | Farrington, CR |
| ^ | calc-ox | Buchner, CR |
| ^ | carc | Goswami, CR |
| ^ | card-m | banj |
| ^ | cean | gm1, rmk, sne |
| ^ | chel | banj, wrj2, sne |
| ^ | coloc | wrj2, rzh |
| ^ | con | lwd** banj |
| ^ | euph | sne |
| ^ | hydr | rmk1, banj, wrj2! |
| ^ | iod | bn11 |
| ^ | ion-rad | Sherr, CR |
| ^ | iris | lby5, p2 |
| ^ | kali-ar | Goswami, CR |
| ^ | kali-i | Goswami, CR |
| ^ | kali-sil | Goswami, CR |
| ^ | lyc | wrj2 |
| ^ | methyl | lby5 |
| ^ | myric | Burnett, CR |
| ^ | nat-s | sne |
| ^ | orni | sgx, sne |
| ^ | phos | snd* ftb in cpb1, wrj1 |
| ^ | psor | A.Chatterje-Study |
| ^ | rad-br | Goswami, CR |
| ^ | rhus-v | Dutt, CR |
| ^ | scir | Goswami, CR |
| ^ | sep | wrj2, sne |
| ^ | sil | lby5 |
| ^ | spong | wrj2 |
| ^ | sul-i | Goswami, CR |
| ^ | sulph | Goswami, CR |
| ^ | thuj | lby5 |
| ^ | vario | sne |
| ^ | x-ray | Goswami, CR |
| ^ | zinc | lby5 |